Medical Developments International (MVP) Stock Price, News & Analysis

Company Overview

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 169,499 shs
• Average Volume: N/A
• Market Capitalization: A$98.01 million
• P/E Ratio: N/A
• Dividend Yield: 0.77%
• Price Target: N/A
• Consensus Rating: N/A

MVP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Medical Developments International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Developments International investors own include Core Lithium (CXO), Bubs Australia (BUB), Talon Energy (TPD), Qantas Airways (QAN), Mesoblast (MESO), LINE (LN) and Harvey Norman (HVN).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:MVP
• CIK: N/A
• Web: www.medicaldev.com
• Phone: 61 3 9547 1888
• Fax: N/A
• Employees: 68
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.46)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$40.99 million
• Net Margins: -123.66%
• Pretax Margin: N/A
• Return on Equity: -67.52%
• Return on Assets: -11.21%

Debt

• Debt-to-Equity Ratio: 5.00
• Current Ratio: 2.74
• Quick Ratio: 2.54

Sales & Book Value

• Annual Sales: A$33.15 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 21.37
• Book Value: A$0.52 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 112,660,000
• Free Float: N/A
• Market Cap: A$98.01 million
• Optionable: Not Optionable
• Beta: 1.63